Logo
x

Search

Subscribe Now

pancreatic cancer

Immunovia Reports Positive Results of Next Generation Test from Model Development Study for Pancreatic Cancer Detection

Immunovia Reports Positive Results of Next Generation Test from Model Development Study for Pancreatic Cancer Detection

  • April 22, 2024
Vigeo Reports Completion of VT1021 in P-I/II Study for the Treatment of Recurrent Glioblastoma and Pancreatic Cancer

Vigeo Reports Completion of VT1021 in P-I/II Study for the Treatment of Recurrent Glioblastoma and Pancreatic Cancer

  • September 22, 2021
PharmaShots Interview: Vigeo Therapeutics' Dr. Lou Vaickus and Dr. Jing Watnick Share Insights on VT1021 Data Presented at SITC 2020

PharmaShots Interview: Vigeo Therapeutics' Dr. Lou Vaickus and Dr. Jing Watnick Share Insights on VT1021 Data Presented at SITC 20...

  • January 15, 2021
Alligator Bioscience Submits CTA for the P-II OPTIMIZE-1 Study of Mitazalimab

Alligator Bioscience Submits CTA for the P-II OPTIMIZE-1 Study of Mitazalimab

  • December 29, 2020
Prestige's PBP1510 Receives EMA's Positive Opinion on Orphan Designation for Pancreatic Cancer

Prestige's PBP1510 Receives EMA's Positive Opinion on Orphan Designation for Pancreatic Cancer

  • October 14, 2020
AstraZeneca's Lynparza (olaparib) Receives MHLW's Orphan Drug Designation for BRCA-Mutated Metastatic Pancreatic Cancer

AstraZeneca's Lynparza (olaparib) Receives MHLW's Orphan Drug Designation for BRCA-Mutated Metastatic Pancreatic Cancer

  • March 19, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.